Shree Ganesh Biotech (India) Ltd — Board Meeting, 25-07-2025: Board Meeting

Shree Ganesh Bio-Tech's board has approved the financial results for the recent quarter. The company announced revenue from operations of 1.38 Cr, alongside a net profit of 0.33 Cr. This performance represents a positive shift compared to the corresponding quarter last year, which saw higher revenue at 3.01 Cr but resulted in a net loss of 0.95 Cr. Shareholders should observe this improved profitability despite lower revenue, indicating better cost management or operational efficiency. This update is key for assessing the company's recent financial health.